Investor Alert

New York Markets Close in:

GW Pharmaceuticals PLC ADR

NAS: GWPH

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 18, 2020, 12:17 p.m.

/zigman2/quotes/209686240/composite

$

100.29

Change

-1.72 -1.69%

Volume

Volume 273,249

Real time quotes

/zigman2/quotes/209686240/composite

Previous close

$ 102.01

$ 100.29

Change

-1.72 -1.69%

Day low

Day high

$99.72

$102.16

Open

52 week low

52 week high

$67.98

$141.98

Open

Annual Financials for GW Pharmaceuticals PLC ADR

Fiscal year is January-December. All values USD millions. 20152016201720182019 5-year trend
Sales/Revenue 44.01M14.58M10.58M15.49M312.62M
Cost of Goods Sold (COGS) incl. D&A 7.42M9.03M11.64M11.01M27.31M
COGS excluding D&A 3.87M3.84M4.55M1.63M18.03M
Depreciation & Amortization Expense 3.55M5.18M7.09M9.38M9.28M
Depreciation 3.47M5.1M6.78M8.49M8.03M
Amortization of Intangibles 80,19187,661314,865892,8881.25M
Gross Income 36.59M5.56M(1.06M)4.48M285.31M
20152016201720182019 5-year trend
SG&A Expense 133.48M164.13M188.8M278.63M408.23M
Research & Development 114.09M141.13M142.87M133.49M147.28M
Other SG&A 19.38M23.01M45.93M145.14M260.96M
Other Operating Expense -----
Unusual Expense 934,531-536,177--
EBIT after Unusual Expense (97.82M)-(536,177)--
Non Operating Income/Expense 9.56M36.13M(6.48M)(2.13M)102.27M
Non-Operating Interest Income 376,280859,6392.08M8.91M8.5M
Equity in Affiliates (Pretax) -----
Interest Expense 115,660244,601956,6681.26M1.09M
Gross Interest Expense 115,660244,601956,6681.26M1.09M
Interest Capitalized -----
Pretax Income (88M)(121.84M)(195.76M)(268.62M)(13.25M)
Income Tax (19.27M)(31.83M)(26.61M)4.07M(4.19M)
Income Tax - Current Domestic --2.15M4.06M-
Income Tax - Current Foreign 564,4201.66M--9.55M
Income Tax - Deferred Domestic (89,444)(2.82M)(3.2M)8,785-
Income Tax - Deferred Foreign ----(9.74M)
Income Tax Credits 19.75M30.68M25.56M-4.01M
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (68.72M)(90M)(169.15M)(272.69M)(9.06M)
Minority Interest Expense -----
Net Income (68.72M)(90M)(169.15M)(272.69M)(9.06M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (68.72M)(90M)(169.15M)(272.69M)(9.06M)
Preferred Dividends -----
Net Income Available to Common (68.72M)(90M)(169.15M)(272.69M)(9.06M)
EPS (Basic) (3.35)(3.99)(6.69)(9.61)(0.29)
Basic Shares Outstanding 20.53M22.53M25.3M28.37M30.97M
EPS (Diluted) (3.35)(3.99)(6.69)(9.61)(0.29)
Diluted Shares Outstanding 20.53M22.53M25.3M28.37M30.97M
EBITDA (93.34M)(153.39M)(182.76M)(264.77M)(113.65M)
Link to MarketWatch's Slice.